This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Name of resource
Galway Neuroscience Cluster
Name of Principal Investigator
| Title | Dr |
| First name | David |
| Last name | Finn |
Address of institution where award is held
| Institution | National University of Ireland, Galway |
| Street Address | Pharmacology and Therapeutics, University Road |
| City | Galway |
| Postcode | Eire |
Country
Website
http://ncbes.nuigalway.ie/neuroscience.aspx
Contact email
[email protected]
Summary
1a. The resource holds animal models relevant to the study of the following neurodegenerative diseases
1b. The resource holds:
2a. The resource acts as a centre for access and distribution to external groups (who are not the PIs of the resource)
2b. Procedures and rules for access
3a. Does the resource develop animal models for external groups
2
3b. Types of models provided
4a This activity is supported as:
5a Disease models available
| Disease | Species | Available to external user (Y/N) | Full phenotypic character (Y/N or partial) | Phenotypes | Genotypes or other subtypes |
| rat | Y | Y | motor impairment; nigro-striatal neurodegeneration |
5b. Other models/phenotypes available through the resource relevant to neurodegenerative conditions
| No. of models | Available to external users | Full phenotypic characterisation available (Y/N or partial) | Nature of phenotype |
| 4 | Y | Y | Morris water maze; novel object recognition; T-maze; passive avoidance |
| 2 | Y | Y | Automated home cage and novel arena locomotor monitoring systems |
| 1 | Y | Y | In vivo microdialysis |
| neuroimmune signalling and pain | Y | Y |
7a. Maintenance of the resource is dependent on continued funding
1
7b. End date of current funding period
N/A
7c. Expected lifespan of the resource (in years)
10
Galway Neuroscience Cluster
Experimental Models
Ireland
Neurodegenerative disease in general|Parkinson’s disease & PD-related disorders
2011
